Posted On: 03/11/2015 11:15:12 AM
Post# of 30015
Odds are it won't. Remember GC mentioning that he'd talk about Lympro rev guidance and WE NEVER EVER GOT IT? I wonder why? Lympro might actually have to be renamed to LIMPro as it is becoming obvious that the company is having a hard time getting BP to use it. I hope that changes once those so called peer review journal articles come out.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.